FRAZIER KENNETH C — SEC Form 4 filings
SEC reporting owner CIK 1181175. 2 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2026-02-06 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 111,111 shares, $1,999,998 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 111,111 shares @ $18.00 ($1,999,998) in Eikon Therapeutics, Inc., filed 2026-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. (EIKN) | Director | 2 | 1 leg · 111,111 sh · $1,999,998 | — | 1 |
Form 4 filings — FRAZIER KENNETH C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Eikon Therapeutics, Inc. (EIKN) | Grant/award (A): 25,873 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Eikon Therapeutics, Inc. (EIKN) | Purchase (P): 111,111 @ $18 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1181175 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →